{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:54:38Z","timestamp":1784346878374,"version":"3.55.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Gujarat State Biotechnology Mission, Government of Gujarat, India","award":["GSBTM\/MD\/PROJECTS\/SSA\/4887\/2016-17"],"award-info":[{"award-number":["GSBTM\/MD\/PROJECTS\/SSA\/4887\/2016-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11064-026-04721-x","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:05:04Z","timestamp":1774868704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vitamin D3 Attenuates Alzheimer\u2019s Disease-Like Pathology via Remodeling Amyloid Protein Production and Clearance Pathway in Wistar Rats"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7910-9473","authenticated-orcid":false,"given":"Parmi","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-4526","authenticated-orcid":false,"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"4721_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer\u2019s disease. Nature 430:631\u2013639. https:\/\/doi.org\/10.1038\/nature02621","journal-title":"Nature"},{"issue":"Suppl 2","key":"4721_CR2","doi-asserted-by":"publisher","first-page":"S499","DOI":"10.3233\/JAD-2010-100504","volume":"20","author":"PH Reddy","year":"2010","unstructured":"Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U (2010) Amyloid-beta and mitochondria in aging and Alzheimer\u2019s disease: implications for synaptic damage and cognitive decline. J Alzheimers Dis 20(Suppl 2):S499-512. https:\/\/doi.org\/10.3233\/JAD-2010-100504","journal-title":"J Alzheimers Dis"},{"key":"4721_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.741","journal-title":"Physiol Rev"},{"key":"4721_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1871527319666200214104331","volume":"19","author":"WN Chen","year":"2020","unstructured":"Chen WN, Yeong KY (2020) Scopolamine, a toxin-induced experimental model, used for research in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 19:85\u201393. https:\/\/doi.org\/10.2174\/1871527319666200214104331","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"4721_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"key":"4721_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"4721_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1582-4934.2008.00225.x","volume":"12","author":"K Iqbal","year":"2008","unstructured":"Iqbal K, Grundke-Iqbal I (2008) Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12:38\u201355. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00225.x","journal-title":"J Cell Mol Med"},{"key":"4721_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25\u00a0years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"4721_CR9","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff L, Daley D, Black KL, Koronyo-Hamaoui M (2017) Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci 74:2167\u20132201. https:\/\/doi.org\/10.1007\/s00018-017-2463-7","journal-title":"Cell Mol Life Sci"},{"key":"4721_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fchem.2019.00472","volume":"7","author":"JK Kasim","year":"2019","unstructured":"Kasim JK, Kavianinia I, Harris PWR, Brimble MA (2019) Three decades of amyloid beta synthesis: challenges and advances. Front Chem 7:472","journal-title":"Front Chem"},{"key":"4721_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00160","author":"M Ries","year":"2016","unstructured":"Ries M, Sastre M (2016) Mechanisms of A\u03b2 clearance and degradation by glial cells. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2016.00160","journal-title":"Front Aging Neurosci"},{"key":"4721_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.01.041","author":"YX Guo","year":"2016","unstructured":"Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX (2016) 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing A\u03b21-40 brain-to-blood efflux and peripheral uptake transport. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.041","journal-title":"Neuroscience"},{"key":"4721_CR13","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease. Science 330:1774\u20131774. https:\/\/doi.org\/10.1126\/science.1197623","journal-title":"Science"},{"key":"4721_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH (2017) Amyloid Beta and Phosphorylated Tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimers Dis 57:975\u2013999. https:\/\/doi.org\/10.3233\/JAD-160612","journal-title":"J Alzheimers Dis"},{"key":"4721_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"4721_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines9050524","volume":"9","author":"IG Onyango","year":"2021","unstructured":"Onyango IG, Jauregui GV, \u010carn\u00e1 M, Bennett JP, Stokin GB (2021) Neuroinflammation in Alzheimer\u2019s Disease. Biomedicines 9:524. https:\/\/doi.org\/10.3390\/biomedicines9050524","journal-title":"Biomedicines"},{"key":"4721_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y, Li H, Wu Y (2019) The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 13:43. https:\/\/doi.org\/10.3389\/fnins.2019.00043","journal-title":"Front Neurosci"},{"key":"4721_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry","year":"2003","unstructured":"Terry AV, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821\u2013827. https:\/\/doi.org\/10.1124\/jpet.102.041616","journal-title":"J Pharmacol Exp Ther"},{"key":"4721_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6:19. https:\/\/doi.org\/10.1177\/1756285612461679","journal-title":"Ther Adv Neurol Disord"},{"key":"4721_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000350319","volume":"36","author":"E Dursun","year":"2013","unstructured":"Dursun E, Gezen-Ak D, Yilmazer S (2013) Beta amyloid suppresses the expression of the Vitamin D receptor gene and induces the expression of the Vitamin D catabolic enzyme gene in hippocampal neurons. Dement Geriatr Cogn Disord 36:76\u201386. https:\/\/doi.org\/10.1159\/000350319","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4721_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JAD-131970","volume":"40","author":"D Gezen-Ak","year":"2014","unstructured":"Gezen-Ak D, Y\u0131lmazer S, Dursun E (2014) Why Vitamin D in Alzheimer\u2019s Disease? The hypothesis. J Alzheimers Dis 40:257\u2013269. https:\/\/doi.org\/10.3233\/JAD-131970","journal-title":"J Alzheimers Dis"},{"key":"4721_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jsbmb.2004.03.062","volume":"89\u201390","author":"B Diesel","year":"2004","unstructured":"Diesel B, Seifert M, Radermacher J, Fischer U, Tilgen W, Reichrath J, Meese E (2004) Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D31alpha-hydroxylase in brain and skin cancer. J Steroid Biochem Mol Biol 89\u201390:527\u2013532. https:\/\/doi.org\/10.1016\/j.jsbmb.2004.03.062","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4721_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s004030050445","volume":"291","author":"B Lehmann","year":"1999","unstructured":"Lehmann B, Tiebel O, Meurer M (1999) Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study. Arch Dermatol Res 291:507\u2013510. https:\/\/doi.org\/10.1007\/s004030050445","journal-title":"Arch Dermatol Res"},{"key":"4721_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0891988708327888","volume":"22","author":"DJ Llewellyn","year":"2009","unstructured":"Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22:188\u2013195. https:\/\/doi.org\/10.1177\/0891988708327888","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"4721_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12404","volume":"15","author":"M Ghahremani","year":"2023","unstructured":"Ghahremani M, Smith EE, Chen H, Creese B, Goodarzi Z, Ismail Z (2023) Vitamin D supplementation and incident dementia: effects of sex, APOE, and baseline cognitive status. Alzheimers Dement Amst 15:e12404. https:\/\/doi.org\/10.1002\/dad2.12404","journal-title":"Alzheimers Dement Amst"},{"key":"4721_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/1567205011310040006","volume":"10","author":"SC Correia","year":"2013","unstructured":"Correia SC, Santos RX, Santos MS, Casadesus G, Lamanna JC, Perry G, Smith MA, Moreira PI (2013) Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer\u2019s disease. Curr Alzheimer Res 10:406\u2013419. https:\/\/doi.org\/10.2174\/1567205011310040006","journal-title":"Curr Alzheimer Res"},{"key":"4721_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JAD-2012-120958","volume":"33","author":"J Mehla","year":"2013","unstructured":"Mehla J, Pahuja M, Gupta YK (2013) Streptozotocin-induced sporadic Alzheimer\u2019s disease: selection of appropriate dose. J Alzheimers Dis 33:17\u201321. https:\/\/doi.org\/10.3233\/JAD-2012-120958","journal-title":"J Alzheimers Dis"},{"key":"4721_CR28","first-page":"337","volume":"9","author":"A Verma","year":"2016","unstructured":"Verma A, Goyal A, Kaur R, Kamboj A, Jain U (2016) Beneficial effect of vitamin D on high-fat diet-induced obesity in wistar rats. Asian J Pharm Clin Res 9:337\u2013340","journal-title":"Asian J Pharm Clin Res"},{"key":"4721_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopha.2018.03.115","volume":"102","author":"P Barai","year":"2018","unstructured":"Barai P, Raval N, Acharya S, Acharya N (2018) Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats. Biomed Pharmacother 102:966\u2013980. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.115","journal-title":"Biomed Pharmacother"},{"key":"4721_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbr.2018.08.010","volume":"356","author":"P Barai","year":"2019","unstructured":"Barai P, Raval N, Acharya S, Borisa A, Bhatt H, Acharya N (2019) Neuroprotective effects of bergenin in Alzheimer\u2019s disease: investigation through molecular docking, in vitro and in vivo studies. Behav Brain Res 356:18\u201340. https:\/\/doi.org\/10.1016\/j.bbr.2018.08.010","journal-title":"Behav Brain Res"},{"key":"4721_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/2920","author":"K Bromley-Brits","year":"2011","unstructured":"Bromley-Brits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer\u2019s disease model mice. JoVE. https:\/\/doi.org\/10.3791\/2920","journal-title":"JoVE"},{"key":"4721_CR32","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s00213-021-05942-4","volume":"238","author":"N Bruszt","year":"2021","unstructured":"Bruszt N, Bali ZK, Tadepalli SA, Nagy LV, Hern\u00e1di I (2021) Potentiation of cognitive enhancer effects of Alzheimer\u2019s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task. Psychopharmacol Berl 238:3273\u20133281. https:\/\/doi.org\/10.1007\/s00213-021-05942-4","journal-title":"Psychopharmacol Berl"},{"key":"4721_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0023-9690(81)90020-5","volume":"12","author":"RGM Morris","year":"1981","unstructured":"Morris RGM (1981) Spatial localization does not require the presence of local cues. Learn Motiv 12:239\u2013260. https:\/\/doi.org\/10.1016\/0023-9690(81)90020-5","journal-title":"Learn Motiv"},{"key":"4721_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848\u2013858. https:\/\/doi.org\/10.1038\/nprot.2006.116","journal-title":"Nat Protoc"},{"key":"4721_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0006-899(97)00236-9","volume":"759","author":"CD Conrad","year":"1997","unstructured":"Conrad CD, Lupien SJ, Thanasoulis LC, McEwen BS (1997) The effects of type I and type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze. Brain Res 759:76\u201383. https:\/\/doi.org\/10.1016\/S0006-899(97)00236-9","journal-title":"Brain Res"},{"key":"4721_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","volume":"18","author":"X Sun","year":"2021","unstructured":"Sun X, Li L, Dong Q-X, Zhu J, Huang Y, Hou S, Yu X, Liu R (2021) Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 18:131. https:\/\/doi.org\/10.1186\/s12974-021-02182-3","journal-title":"J Neuroinflammation"},{"key":"4721_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137062","volume":"22","author":"LC Camargo","year":"2021","unstructured":"Camargo LC, Sch\u00f6neck M, Sangarapillai N, Honold D, Shah NJ, Langen K-J, Willbold D, Kutzsche J, Schemmert S, Willuweit A (2021) PEA\u03b2 triggers cognitive decline and amyloid burden in a novel mouse model of Alzheimer\u2019s disease. IJMS 22:7062. https:\/\/doi.org\/10.3390\/ijms22137062","journal-title":"IJMS"},{"key":"4721_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"4721_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"4721_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"key":"4721_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000136485","volume":"11","author":"DJ Jollow","year":"1974","unstructured":"Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-Bromobenzene Oxide as the hepatotoxic metabolite. Pharmacology 11:151\u2013169. https:\/\/doi.org\/10.1159\/000136485","journal-title":"Pharmacology"},{"key":"4721_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0003-2697(78)90010-6","volume":"90","author":"M Sun","year":"1978","unstructured":"Sun M, Zigman S (1978) An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem 90:81\u201389. https:\/\/doi.org\/10.1016\/0003-2697(78)90010-6","journal-title":"Anal Biochem"},{"key":"4721_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/aps.2013.203","volume":"35","author":"L-L Zhang","year":"2014","unstructured":"Zhang L-L, Sui H-J, Liang B, Wang H-M, Qu W-H, Yu S-X, Jin Y (2014) Atorvastatin prevents amyloid-\u03b2 peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway. Acta Pharmacol Sin 35:716\u2013726. https:\/\/doi.org\/10.1038\/aps.2013.203","journal-title":"Acta Pharmacol Sin"},{"key":"4721_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00195-1","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian D-Y, Wang Y-J (2020) Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener 9:16. https:\/\/doi.org\/10.1186\/s40035-020-00195-1","journal-title":"Transl Neurodegener"},{"key":"4721_CR45","doi-asserted-by":"publisher","DOI":"10.55782\/ane-2024-2486","author":"SY Saleh","year":"2024","unstructured":"Saleh SY, Sadeghi L, Dehghan G (2024) Investigation of amyloid-\u03b2 peptide production and clearance pathways in different stages of Alzheimer\u2019s disease. Acta Neurobiol Exp. https:\/\/doi.org\/10.55782\/ane-2024-2486","journal-title":"Acta Neurobiol Exp"},{"key":"4721_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00098","author":"MO Grimm","year":"2013","unstructured":"Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T (2013) Neprilysin and A\u03b2 clearance: impact of the APP Intracellular Domain in NEP regulation and implications in Alzheimer\u2019s Disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2013.00098","journal-title":"Front Aging Neurosci"},{"key":"4721_CR47","doi-asserted-by":"publisher","first-page":"29645","DOI":"10.1074\/jbc.R800022200","volume":"283","author":"MA Leissring","year":"2008","unstructured":"Leissring MA (2008) The AbetaCs of Abeta-cleaving proteases. J Biol Chem 283:29645\u201329649. https:\/\/doi.org\/10.1074\/jbc.R800022200","journal-title":"J Biol Chem"},{"key":"4721_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01132-2","volume":"14","author":"F Rofo","year":"2022","unstructured":"Rofo F, Metzendorf NG, Saubi C, Suominen L, Godec A, Sehlin D, Syv\u00e4nen S, Hultqvist G (2022) Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer\u2019s disease. Alzheimers Res Ther 14:180. https:\/\/doi.org\/10.1186\/s13195-022-01132-2","journal-title":"Alzheimers Res Ther"},{"key":"4721_CR49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrn4019","volume":"16","author":"GJ Biessels","year":"2015","unstructured":"Biessels GJ, Reagan LP (2015) Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci 16:660\u2013671. https:\/\/doi.org\/10.1038\/nrn4019","journal-title":"Nat Rev Neurosci"},{"key":"4721_CR50","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","volume":"96","author":"S Kullmann","year":"2016","unstructured":"Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, H\u00e4ring H-U (2016) Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev 96:1169\u20131209. https:\/\/doi.org\/10.1152\/physrev.00032.2015","journal-title":"Physiol Rev"},{"key":"4721_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911562","volume":"23","author":"M \u010cater","year":"2022","unstructured":"\u010cater M, H\u00f6lter SM (2022) A pathophysiological intersection of diabetes and Alzheimer\u2019s disease. IJMS 23:11562. https:\/\/doi.org\/10.3390\/ijms231911562","journal-title":"IJMS"},{"key":"4721_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106358","volume":"182","author":"BJ Dutta","year":"2022","unstructured":"Dutta BJ, Singh S, Seksaria S, Das Gupta G, Singh A (2022) Inside the diabetic brain: insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies. Pharmacol Res 182:106358. https:\/\/doi.org\/10.1016\/j.phrs.2022.106358","journal-title":"Pharmacol Res"},{"key":"4721_CR53","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/WNL.0000000000000452","volume":"82","author":"SY Ryu","year":"2014","unstructured":"Ryu SY, Coutu J-P, Rosas HD, Salat DH (2014) Effects of insulin resistance on white matter microstructure in middle-aged and older adults. Neurology 82:1862\u20131870. https:\/\/doi.org\/10.1212\/WNL.0000000000000452","journal-title":"Neurology"},{"key":"4721_CR54","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Gu\u00e9nette S (2003) Insulin-degrading enzyme regulates the levels of insulin, Amyloid \u03b2-protein, and the \u03b2-Amyloid Precursor Protein Intracellular Domain in vivo. Proc Natl Acad Sci U S A 100:4162\u20134167. https:\/\/doi.org\/10.1073\/pnas.0230450100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4721_CR55","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","volume":"164","author":"W Farris","year":"2004","unstructured":"Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ (2004) Partial loss-of-function mutations in Insulin-Degrading Enzyme that induce diabetes also impair degradation of Amyloid \u03b2-Protein. Am J Pathol 164:1425\u20131434. https:\/\/doi.org\/10.1016\/S0002-9440(10)63229-4","journal-title":"Am J Pathol"},{"key":"4721_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF03346691","volume":"34","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu L, Lu S, Wang D, Liu X, Xie L, Wang G (2011) Impaired amyloid \u03b2-degrading enzymes in brain of streptozotocin-induced diabetic rats. J Endocrinol Invest 34:26\u201331. https:\/\/doi.org\/10.1007\/BF03346691","journal-title":"J Endocrinol Invest"},{"key":"4721_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-med-051022-043645","volume":"75","author":"JL Heidebrink","year":"2024","unstructured":"Heidebrink JL, Paulson HL (2024) Lessons learned from approval of Aducanumab for Alzheimer\u2019s disease. Annu Rev Med 75:99\u2013111. https:\/\/doi.org\/10.1146\/annurev-med-051022-043645","journal-title":"Annu Rev Med"},{"key":"4721_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0306-4522(01)00049-5","volume":"104","author":"MC Langub","year":"2001","unstructured":"Langub MC, Herman JP, Malluche HH, Koszewski NJ (2001) Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 104:49\u201356. https:\/\/doi.org\/10.1016\/s0306-4522(01)00049-5","journal-title":"Neuroscience"},{"key":"4721_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14737175.2021.1873768","volume":"21","author":"F Panza","year":"2021","unstructured":"Panza F, La Montagna M, Lampignano L, Zupo R, Bortone I, Castellana F, Sardone R, Borraccino L, Dibello V, Resta E, Altamura M, Daniele A, Lozupone M (2021) Vitamin D in the development and progression of alzheimer\u2019s disease: implications for clinical management. Expert Rev Neurother 21:287\u2013301. https:\/\/doi.org\/10.1080\/14737175.2021.1873768","journal-title":"Expert Rev Neurother"},{"key":"4721_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124215","volume":"21","author":"C-I Lin","year":"2020","unstructured":"Lin C-I, Chang Y-C, Kao N-J, Lee W-J, Cross T-W, Lin S-H (2020) 1,25(OH)2D3 alleviates A\u03b2(25-35)-induced tau hyperphosphorylation, excessive reactive oxygen species, and apoptosis through interplay with glial cell line-derived neurotrophic factor signaling in SH-SY5Y cells. Int J Mol Sci 21:4215. https:\/\/doi.org\/10.3390\/ijms21124215","journal-title":"Int J Mol Sci"},{"key":"4721_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-2012-110560","volume":"29","author":"MT Mizwicki","year":"2012","unstructured":"Mizwicki MT, Menegaz D, Zhang J, Barrientos-Dur\u00e1n A, Tse S, Cashman JR, Griffin PR, Fiala M (2012) Genomic and nongenomic signaling induced by 1\u03b1,25(OH)2-vitamin D3 promotes the recovery of amyloid-\u03b2 phagocytosis by Alzheimer\u2019s disease macrophages. J Alzheimers Dis 29:51\u201362. https:\/\/doi.org\/10.3233\/JAD-2012-110560","journal-title":"J Alzheimers Dis"},{"key":"4721_CR62","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.3390\/ijms18122764","volume":"18","author":"MOW Grimm","year":"2017","unstructured":"Grimm MOW, Thiel A, Lauer AA, Winkler J, Lehmann J, Regner L, Nelke C, Janitschke D, Benoist C, Streidenberger O, St\u00f6tzel H, Endres K, Herr C, Beisswenger C, Grimm HS, Bals R, Lammert F, Hartmann T (2017) Vitamin D and its analogues decrease Amyloid-\u03b2 (A\u03b2) formation and increase A\u03b2-degradation. Int J Mol Sci 18:2764. https:\/\/doi.org\/10.3390\/ijms18122764","journal-title":"Int J Mol Sci"},{"key":"4721_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113375","volume":"153","author":"M Fan","year":"2022","unstructured":"Fan M, Liu S, Sun H-M, Ma M-D, Gao Y-J, Qi C-C, Xia Q-R, Ge J-F (2022) Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: involved with the fundamental role of neuroinflammation. Biomed Pharmacother 153:113375. https:\/\/doi.org\/10.1016\/j.biopha.2022.113375","journal-title":"Biomed Pharmacother"},{"key":"4721_CR64","doi-asserted-by":"publisher","first-page":"e3397","DOI":"10.21769\/BioProtoc.3397","volume":"9","author":"D Moreira-Silva","year":"2019","unstructured":"Moreira-Silva D, Vizin RCL, Martins TMS, Ferreira TL, Almeida MC, Carrettiero DC (2019) Intracerebral injection of streptozotocin to model Alzheimer disease in rats. Bio Protoc 9:e3397. https:\/\/doi.org\/10.21769\/BioProtoc.3397","journal-title":"Bio Protoc"},{"key":"4721_CR65","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1037\/0735-7044.112.5.1199","volume":"112","author":"H Lannert","year":"1998","unstructured":"Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199\u20131208. https:\/\/doi.org\/10.1037\/0735-7044.112.5.1199","journal-title":"Behav Neurosci"},{"key":"4721_CR66","doi-asserted-by":"publisher","first-page":"474","DOI":"10.22038\/IJBMS.2017.8669","volume":"20","author":"L Wang","year":"2017","unstructured":"Wang L, Liu W, Fan Y, Liu T, Yu C (2017) Effect of rosiglitazone on amyloid precursor protein processing and A\u03b2 clearance in streptozotocin-induced rat model of Alzheimer\u2019s disease. Iran J Basic Med Sci 20:474\u2013480. https:\/\/doi.org\/10.22038\/IJBMS.2017.8669","journal-title":"Iran J Basic Med Sci"},{"key":"4721_CR67","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2353\/ajpath.2009.090157","volume":"175","author":"Y Deng","year":"2009","unstructured":"Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong C-X (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer\u2019s disease. Am J Pathol 175:2089\u20132098. https:\/\/doi.org\/10.2353\/ajpath.2009.090157","journal-title":"Am J Pathol"},{"key":"4721_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.148175","volume":"1799","author":"SSL Silva","year":"2023","unstructured":"Silva SSL, Tureck LV, Souza LC, Mello-Hortega JV, Piumbini AL, Teixeira MD, Furtado-Alle L, Vital MABF, Souza RLR (2023) Animal model of Alzheimer\u2019s disease induced by streptozotocin: new insights about cholinergic pathway. Brain Res 1799:148175. https:\/\/doi.org\/10.1016\/j.brainres.2022.148175","journal-title":"Brain Res"},{"key":"4721_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40795-023-00767-0","volume":"9","author":"MK Trivedi","year":"2023","unstructured":"Trivedi MK, Branton A, Trivedi D, Mondal S, Jana S (2023) Vitamin D3 supplementation improves spatial memory, muscle function, pain score, and modulates different functional physiological biomarkers in vitamin D3 deficiency diet (VDD)-induced rats model. BMC Nutr 9:108. https:\/\/doi.org\/10.1186\/s40795-023-00767-0","journal-title":"BMC Nutr"},{"key":"4721_CR70","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","volume":"34","author":"MR Durk","year":"2014","unstructured":"Durk MR, Han K, Chow ECY, Ahrens R, Henderson JT, Fraser PE, Pang KS (2014) 1\u03b1,25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease. J Neurosci 34:7091\u20137101. https:\/\/doi.org\/10.1523\/JNEUROSCI.2711-13.2014","journal-title":"J Neurosci"},{"key":"4721_CR71","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","volume":"167","author":"A Boonstra","year":"2001","unstructured":"Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O\u2019Garra A (2001) 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974\u20134980. https:\/\/doi.org\/10.4049\/jimmunol.167.9.4974","journal-title":"J Immunol"},{"key":"4721_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphar.2020.00161","volume":"11","author":"LR De Oliveira","year":"2020","unstructured":"De Oliveira LR, Mimura LA, Fraga-Silva TF, Ishikawa LL, Fernandes AA, Zorzella-Pezavento SF, Sartori A (2020) Calcitriol prevents neuroinflammation and reduces blood-brain barrier disruption and local macrophage\/microglia activation. Front Pharmacol 11:161. https:\/\/doi.org\/10.3389\/fphar.2020.00161","journal-title":"Front Pharmacol"},{"key":"4721_CR73","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","volume":"106","author":"G Penna","year":"2005","unstructured":"Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106:3490\u20133497. https:\/\/doi.org\/10.1182\/blood-2005-05-2044","journal-title":"Blood"},{"key":"4721_CR74","doi-asserted-by":"publisher","first-page":"110314","DOI":"10.1016\/j.intimp.2023.110314","volume":"120","author":"J Sadeghzadeh","year":"2023","unstructured":"Sadeghzadeh J, Jafarzadeh J, Hadinezhad P, Nazari A, Sohrabi S, Musazadeh V, Barzegar A, Shahabi P (2023) Profiling inflammatory mechanisms, hyperphosphorylated tau of hippocampal tissue and spatial memory following vitamin D3 treatment in the mice model of vascular dementia. Int Immunopharmacol 120:110314. https:\/\/doi.org\/10.1016\/j.intimp.2023.110314","journal-title":"Int Immunopharmacol"},{"key":"4721_CR75","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1210\/jc.2008-1212","volume":"94","author":"O Tarcin","year":"2009","unstructured":"Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94:4023\u20134030. https:\/\/doi.org\/10.1210\/jc.2008-1212","journal-title":"J Clin Endocrinol Metab"},{"key":"4721_CR76","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00210-023-02449-x","volume":"396","author":"MM Elseweidy","year":"2023","unstructured":"Elseweidy MM, Mahrous M, Ali SI, Shaheen MA, Younis NN (2023) RETRACTED ARTICLE: Vitamin D alleviates cognitive dysfunction and brain damage induced by copper sulfate intake in experimental rats: focus on its combination with donepezil. Naunyn Schmiedebergs Arch Pharmacol 396:1931\u20131942. https:\/\/doi.org\/10.1007\/s00210-023-02449-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4721_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000355462","volume":"13","author":"MOW Grimm","year":"2014","unstructured":"Grimm MOW, Lehmann J, Mett J, Zimmer VC, Gr\u00f6sgen S, Stahlmann CP, Hundsd\u00f6rfer B, Haupenthal VJ, Rothhaar TL, Herr C, Bals R, Grimm HS, Hartmann T (2014) Impact of vitamin D on amyloid precursor protein processing and amyloid-\u03b2 peptide degradation in Alzheimer\u2019s disease. Neurodegener Dis 13:75\u201381. https:\/\/doi.org\/10.1159\/000355462","journal-title":"Neurodegener Dis"},{"key":"4721_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-8-20","volume":"8","author":"S Ito","year":"2011","unstructured":"Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T (2011) 1\u03b1,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-\u03b2 peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8:20. https:\/\/doi.org\/10.1186\/2045-8118-8-20","journal-title":"Fluids Barriers CNS"},{"key":"4721_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JAD-2009-1080","volume":"17","author":"A Masoumi","year":"2009","unstructured":"Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwicki M, Cashman J, Fiala M (2009) 1\u03b1,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-\u03b2 clearance by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis 17:703\u2013717. https:\/\/doi.org\/10.3233\/JAD-2009-1080","journal-title":"J Alzheimers Dis"},{"key":"4721_CR80","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures (2023) Alzheimer\u2019s & Dementia. 19:1598\u20131695. https:\/\/doi.org\/10.1002\/alz.13016","DOI":"10.1002\/alz.13016"},{"key":"4721_CR81","doi-asserted-by":"publisher","first-page":"718","DOI":"10.14283\/jpad.2023.114","volume":"10","author":"M Barbera","year":"2023","unstructured":"Barbera M, Perera D, Matton A, Mangialasche F, Rosenberg A, Middleton L, Ngandu T, Solomon A, Kivipelto M (2023) Multimodal precision prevention - a new direction in Alzheimer\u2019s disease. J Prevent Alzheimer\u2019s Dis 10:718\u2013728. https:\/\/doi.org\/10.14283\/jpad.2023.114","journal-title":"J Prevent Alzheimer\u2019s Dis"},{"key":"4721_CR82","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319\u2013329. https:\/\/doi.org\/10.1016\/j.chembiol.2013.12.016","journal-title":"Chem Biol"},{"key":"4721_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113672","volume":"13","author":"Z G\u00e1ll","year":"2021","unstructured":"G\u00e1ll Z, Sz\u00e9kely O (2021) Role of Vitamin D in cognitive dysfunction: new molecular concepts and discrepancies between animal and human findings. Nutrients 13:3672. https:\/\/doi.org\/10.3390\/nu13113672","journal-title":"Nutrients"},{"key":"4721_CR85","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, Strooper BD (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698\u2013712. https:\/\/doi.org\/10.1038\/nrd3505","journal-title":"Nat Rev Drug Discov"},{"key":"4721_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/joim.12308","volume":"277","author":"MF Holick","year":"2015","unstructured":"Holick MF (2015) Vitamin D and brain health: the need for vitamin D supplementation and sensible sun exposure. J Intern Med 277:90\u201393. https:\/\/doi.org\/10.1111\/joim.12308","journal-title":"J Intern Med"},{"key":"4721_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP (2010) Neuropathology of Alzheimer\u2019s Disease. Mt Sinai J Med 77:32\u201342. https:\/\/doi.org\/10.1002\/msj.20157","journal-title":"Mt Sinai J Med"},{"key":"4721_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11010032","volume":"11","author":"A Rashad","year":"2022","unstructured":"Rashad A, Rasool A, Shaheryar M, Sarfraz A, Sarfraz Z, Robles-Velasco K, Cherrez-Ojeda I (2022) Donanemab for Alzheimer\u2019s disease: a systematic review of clinical trials. Healthcare 11:32. https:\/\/doi.org\/10.3390\/healthcare11010032","journal-title":"Healthcare"},{"key":"4721_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00221","author":"X Sun","year":"2015","unstructured":"Sun X, Chen W-D, Wang Y-D (2015) \u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2015.00221","journal-title":"Front. Pharmacol."},{"key":"4721_CR91","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","volume":"20","author":"S-S Yoon","year":"2012","unstructured":"Yoon S-S, Jo SA (2012) Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol Ther (Seoul) 20:245\u2013255. https:\/\/doi.org\/10.4062\/biomolther.2012.20.3.245","journal-title":"Biomol Ther (Seoul)"},{"key":"4721_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00359","author":"X Zhang","year":"2018","unstructured":"Zhang X, Fu Z, Meng L, He M, Zhang Z (2018) The early events that initiate \u03b2-amyloid aggregation in Alzheimer\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2018.00359","journal-title":"Front Aging Neurosci"},{"key":"4721_CR93","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1111\/febs.16939","volume":"291","author":"J \u017bukowska","year":"2024","unstructured":"\u017bukowska J, Moss SJ, Subramanian V, Acharya KR (2024) Molecular basis of selective amyloid-\u03b2 degrading enzymes in Alzheimer\u2019s disease. FEBS J 291:2999\u20133029. https:\/\/doi.org\/10.1111\/febs.16939","journal-title":"FEBS J"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04721-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:37:53Z","timestamp":1777261073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04721-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4721"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04721-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests related to the content of this study. The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"128"}}